OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
25
Results
Show all
Save search
Copy query
Show results for
Unknown
(19)
Proteomics
(5)
Transcriptomics
(1)
Organisms
Homo sapiens
(5)
Mus musculus
(1)
Repository
pride
(5)
biostudies-arrayexpress
(1)
Tissue
B cell
(1)
B-lymphocyte
(1)
Lymphocytic leukemia cell
(1)
Malignant cell
(1)
Peripheral blood
(1)
Primary cell line cell
(1)
Stromal cell
(1)
Disease
Chronic lymphocytic leukemia
(3)
Chronic leukemia
(1)
Prolymphocytic leukemia
(1)
Technology Type
Mass Spectrometry
(5)
Shotgun proteomics
(5)
Publication Date
2022
(4)
2012
(1)
2021
(1)
Study type
Comparative genomic hybridization by array
(1)
Release Date
2019
(5)
2022
(3)
2021
(3)
2020
(3)
2012
(2)
2026
(1)
2025
(1)
2018
(1)
2017
(1)
Lab affiliation
1. Department I of Internal Medicine, Center for Integrated Oncology (CIO), Aachen-Bonn- Cologne-Duesseldorf, Excellence Cluster for Cellular Stress Response and Aging-Associated Diseases (CECAD), Center for Molecular Medicine Cologne (CMMC), University of Cologne (UoC), 50937 Cologne, Germany 2. Department of Hematology and Cellular Therapy, University of Leipzig, Leipzig, Germany
(2)
Head of the Department, Proteomics Core
(1)
Segal Cancer Proteomics Centre, Lady Davis Institute, Jewish General Hospital, McGill University, Montreal, Canada.
(1)
Wellcome Trust/MRC Cambridge Stem Cell Institute & Department of Haematology, Univeristy of Cambridge, Cambridge, UK.
(1)
Previous
page
1 / 3
You're on page
1
page
2
page
3
Next
page
Sort
by:
Relevance
Page size
10
Cellular origin and pathophysiology of chronic lymphocytic leukemia.
Not available
S-EPMC3501361
|
biostudies-literature
Cite
DNA methylation of chronic lymphocytic leukemia with differential response to chemotherapy.
Not available
S-EPMC7195470
|
biostudies-literature
Cite
Corrigendum to “U-RT1 – A new model for Richter transformation” [Neoplasia Volume 23, Issue 1, January 2021, Pages 140-148]
Not available
S-EPMC12945515
|
biostudies-literature
Cite
Targetable alterations in primary extranodal diffuse large B-cell lymphoma.
Not available
S-EPMC9421950
|
biostudies-literature
Cite
Venetoclax resistance and acquired
BCL2
mutations in chronic lymphocytic leukemia.
Not available
S-EPMC6717583
|
biostudies-literature
Cite
Lamin B1 regulates somatic mutations and progression of B-cell malignancies.
Not available
S-EPMC5808072
|
biostudies-literature
Cite
Frequent evolution of copy number alterations in CLL following first-line treatment with FC(R) is enriched with TP53 alterations: results from the CLL8 trial.
Not available
S-EPMC5332302
|
biostudies-literature
Cite
Time-to-progression after front-line fludarabine, cyclophosphamide, and rituximab chemoimmunotherapy for chronic lymphocytic leukaemia: a retrospective, multicohort study.
Not available
S-EPMC7147008
|
biostudies-literature
Cite
Prognostic impact of prevalent chronic lymphocytic leukemia stereotyped subsets: analysis within prospective clinical trials of the German CLL Study Group (GCLLSG).
Not available
S-EPMC7604575
|
biostudies-literature
Cite
Discovery of Candidate DNA Methylation Cancer Driver Genes.
Not available
S-EPMC8419066
|
biostudies-literature
Cite
Previous
page
1 / 3
You're on page
1
page
2
page
3
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets
